Author

M. J. Nicklin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

D. C. James· 2 shared A. Brown· 1 shared A. O. Johnson· 1 shared J. Grinham· 1 shared J. M. Scarrott· 1 shared J. Price· 1 shared K. L. Tee· 1 shared L. J. Partridge· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

D. C. James

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologyCellsPeer-reviewedJun 7, 2021

ACE2-independent interaction of SARS-CoV-2 spike protein to human epithelial cells can be inhibited by unfractionated heparin

L. J. Partridge, L. Urwin, M. J. Nicklin…·P. N. Monk

This paper shows that SARS-CoV-2 spike protein can interact with human cells without ACE2 and that unfractionated heparin inhibits this interaction.

DOI 10.3390/cells10061419

humanproteomics

𝕏 PostBluesky

BiochemistrybioRxivPreprintJul 31, 2020

Purification of recombinant SARS-CoV-2 spike, its receptor binding domain, and CR3022 mAb for serological assay

K. L. Tee, P. J. Jackson, J. M. Scarrott…·T. S. Wong

The paper describes methods for purifying SARS-CoV-2 spike protein, its receptor binding domain, and CR3022 mAb, and validates their use in serological assays.

DOI 10.1101/2020.07.31.231282

proteomicsexperimental assay

𝕏 PostBluesky